  See all
 |
Articles: Dermatologic Oncology |
Prior Articles
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma
Cancer, 12/29/08
Inhibition of Melanoma Growth by Targeting of Antigen to Dendritic Cells via an Anti-DEC-205 Single-Chain Fragment Variable Molecule
Clinical Cancer Research, 12/29/08 Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma
Cancer Research, 12/29/08 Phase I/II study of ipilimumab for patients with metastatic melanoma
Journal of Clinical Oncology, 12/24/08 Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma
Journal of Clinical Oncology, 12/24/08 Integrating tumor-initiating cells into the paradigm for melanoma targeted therapy
International Journal of Cancer, 12/24/08 Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy
Cancer, 12/23/08 Interferon-[gamma] down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells
International Journal of Cancer, 12/23/08 Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration
Cancer Science, 12/23/08 Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
Clinical Cancer Research, 12/22/08 Inhibition of Mammalian Target of Rapamycin by Rapamycin Causes the Regression of Carcinogen-Induced Skin Tumor Lesions
Clinical Cancer Research, 12/22/08 Effects of High-Dose IFN2b on Regional Lymph Node Metastases of Human Melanoma: Modulation of STAT5, FOXP3, and IL-17
Clinical Cancer Research, 12/22/08 Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation
Cancer Research, 12/22/08 Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy
International Journal of Hematology, 12/19/08 Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells
International Journal of Cancer, 12/16/08 Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas
International Journal of Cancer, 12/16/08 Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): A trial coordinated by the Eastern Cooperative Oncology Group
Journal of Clinical Oncology, 12/15/08 Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
Journal of Clinical Oncology, 12/15/08
Evidence Based Medicine
A Dose-Escalation Study of Aerosolized Sargramostim in the Treatment of Metastatic Melanoma: An NCCTG Study
American Journal of Clinical Oncology, 12/12/08 Missense Polymorphisms in Matrix Metalloproteinase Genes and Skin Cancer Risk
Cancer Epidemiology, Biomarkers & Prevention, 12/12/08
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
